Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis
is made using evaluated clinical criteria. Disease activity and burden are best measured …

Core outcome sets are critically important outcomes that should be measured in clinical
trials. Their absence in atopic dermatitis is a form of research waste and impedes combining …

Atopic dermatitis (AD) is characterized by a heterogenous longitudinal course with varying
severity, flares, and persistence. However, AD course is not routinely assessed in clinical …

Importance Patient values and preferences can inform atopic dermatitis (AD) care.
Systematic summaries of evidence addressing patient values and preferences have not …

Summary Background The Harmonising Outcome Measures for Eczema (HOME) initiative
has established a core outcome set of domains for atopic eczema (AE) clinical trials …

Background Eczema control has been identified as an important outcome by key
stakeholders in eczema research (including patients, carers, healthcare professionals and …

Importance Measuring outcomes in clinical practice can aid patient care, quality
improvement, and real-world evidence generation. The Harmonising Outcome Measures for …

Background Paediatric atopic dermatitis (AD) can be burdensome, affecting mental health
and impairing quality of life for children and caregivers. Comprehensive guidelines exist for …

Importance Clinical trial populations may not reflect clinical practice: knowledge generated
in other settings can inform clinical decision-making. Objective To evaluate self-reported …

Background Limited research has been conducted on the measurement properties of the
Recap of atopic eczema (RECAP) questionnaire, particularly in relation to interpretability …